Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease

Richard Odame Phillips(Kwame Nkrumah University of Science and Technology), Mark Wansbrough‐Jones(St George's, University of London), Kingsley Asiedu(World Health Organization), Justice Abotsi(Komfo Anokye Teaching Hospital), Yaw Ampem Amoako(Kwame Nkrumah University of Science and Technology), Fred Stephen Sarfo(Komfo Anokye Teaching Hospital), W. T. Thompson(Goddard Space Flight Center), Wilson Tuah(Government of the United Kingdom), Mohammed K. Abass(Komfo Anokye Teaching Hospital), Mark Forson(Komfo Anokye Teaching Hospital)
Antimicrobial Agents and Chemotherapy
March 18, 2014
10.1128/aac.02453-14
Cited by 7

Related Papers

Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|5k
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2018|3.6k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
|JAMA Oncology|2019|2.7k
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|2.5k
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|2k